首页 > 市场调查报告书 > 医疗设备

核子医学

市场调查报告书

商品编码

1548174

全球强子治疗市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势和预测

Global Hadron Therapy Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年08月01日 | 出版商:

Value Market Research | 英文 172 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

预计到2032年，全球强子治疗市场的市场规模将从2023年的15.5307亿美元达到近44.2945亿美元，2024-2032年研究期间的复合年增长率为12.35%。

强子疗法，也称为强子束疗法，是一种先进的癌症治疗方法，使用带电粒子（例如重离子或质子）来瞄准并破坏肿瘤细胞。与传统的 X 射线辐射不同，这种疗法由于其精确的剂量分布能力，可以直接向肿瘤提供大剂量的辐射，同时最大限度地减少对周围健康组织的损害。这种疗法利用了强子的物理和生物特性，将其能量更有效地沉积在特定深度（称为布拉格峰）。这种疗法对于治疗深部或放射线抗性肿瘤特别有效。

市场动态

由于对先进癌症治疗方案的需求不断增长，特别是患有复杂或放射抗性肿瘤的患者，强子治疗市场正在经历成长。强子疗法提供了一种精确且有针对性的癌症治疗方法，这对于位于关键器官附近或具有挑战性的解剖位置的肿瘤特别有益。随着对有效且破坏性较小的癌症疗法的需求不断增长，强子疗法的采用预计将会增加。技术进步为市场成长提供了重大机会。粒子加速器技术和治疗计划系统的创新提高了强子治疗的精确度和效率。加速器设计的发展，例如紧凑且具有成本效益的系统，使强子治疗变得更容易获得和负担得起，有可能导致癌症治疗中心更广泛地采用。

对个人化医疗和客製化治疗方法的日益重视推动了市场的发展。强子疗法为特定肿瘤部位提供标靶放射的能力符合个人化癌症护理的更广泛趋势，其中治疗根据个别患者特征和肿瘤概况进行客製化。此外，增加对癌症研究的投资和扩大全球医疗保健基础设施也创造了更多机会。随着越来越多的医疗机构采用包括强子疗法在内的先进癌症治疗技术，预计该市场将显着成长。建立新的强子治疗中心以及与研究机构的合作关係进一步支持市场扩张。然而，强子治疗设备的高成本和治疗设施的复杂性可能会阻碍市场成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球强子治疗市场的每个细分市场进行了包容性评估。强子治疗产业的成长和趋势为这项研究提供了整体方法。

市场区隔

强子治疗市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略家确定相应产品或服务的目标人口统计数据以及即将到来的机会。

按粒子辐射类型

电子束
中子束
阿尔法粒子束
质子束
碳离子束
β粒子束

按申请

小儿癌症
摄护腺癌
肝癌
头颈癌
骨与软组织癌
肺癌
眼癌

按最终用户

政府大学
医院
研究机构

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲强子治疗市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。强子治疗市场的主要参与者包括Koninklijke Philips NV、Optivus Proton Therapy Inc、日立有限公司、住友商事株式会社、三菱电机公司、Elekta、IBA Worldwide、Advanced Oncotherapy、Varian Medical Systems Inc、Mevion Medical Systems、ProNova Solutions、Advanced Oncotherapy、Varian Medical Systems Inc、Mevion Medical Systems、ProNova Solutions、Advanced Oncotherapy、Varian Medical Systems Inc、Mevion Medical Systems、ProNova Solutions、Advanced Oncotherapy、Varian Medical Systems Inc、Mevion Medical Systems、ProNova Solutions Llc、ProTom国际的。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区按国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲按国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 9 章：强子治疗公司的竞争格局

强子治疗市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 10 章：公司简介

顶级公司市占率分析
市场集中度
Koninklijke Philips NV

公司概况
公司收入
产品
最新动态

Optivus Proton Therapy Inc

公司概况
公司收入
产品
最新动态

Hitachi Ltd

公司概况
公司收入
产品
最新动态

Sumitomo Corporation

公司概况
公司收入
产品
最新动态

Mitsubishi Electric Corporation

公司概况
公司收入
产品
最新动态

Elekta

公司概况
公司收入
产品
最新动态

IBA Worldwide

公司概况
公司收入
产品
最新动态

Advanced Oncotherapy

公司概况
公司收入
产品
最新动态

Varian Medical Systems Inc

公司概况
公司收入
产品
最新动态

Mevion Medical Systems

公司概况
公司收入
产品
最新动态

ProNova Solutions Llc

公司概况
公司收入
产品
最新动态

ProTom International

公司概况
公司收入
产品
最新动态

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

简介目录图表

Product Code: VMR112115521

The global demand for Hadron Therapy Market is presumed to reach the market size of nearly USD 4429.45 Million by 2032 from USD 1553.07 Million in 2023 with a CAGR of 12.35% under the study period 2024-2032.

Hadron therapy, also known as hadron beam therapy, is an advanced cancer treatment that uses charged particles, such as heavy ions or protons, to target and destroy tumor cells. Unlike traditional X-ray radiation, this therapy delivers large doses of radiation directly to the tumor while minimizing damage to surrounding healthy tissues, thanks to its precise dose distribution capabilities. This therapy exploits hadrons' physical and biological characteristics, which deposit their energy more effectively at a specific depth, known as the Bragg peak. This therapy is particularly effective for treating deep-seated or radio-resistant tumors.

MARKET DYNAMICS

The hadron therapy market is experiencing growth driven by the increasing demand for advanced cancer treatment options, particularly for patients with complex or radiation-resistant tumors. Hadron therapy offers a precise and targeted approach to cancer treatment, which is particularly beneficial for tumors located near critical organs or in challenging anatomical positions. As the need for effective and less damaging cancer therapies grows, the adoption of hadron therapy is expected to rise. Technological advancements present significant opportunities for market growth. Innovations in particle accelerator technology and treatment planning systems enhance the precision and efficiency of hadron therapy. Developments in accelerator designs, such as compact and cost-effective systems, are making hadron therapy more accessible and affordable, potentially leading to broader adoption in cancer treatment centers.

The rising emphasis on personalized medicine & tailored treatment approaches drives the market. Hadron therapy's ability to deliver targeted radiation to specific tumor sites aligns with the broader trend of personalized cancer care, where treatments are customized based on individual patient characteristics & tumor profiles. Furthermore, increasing investments in cancer research and expanding healthcare infrastructure globally create additional opportunities. As more healthcare facilities adopt advanced cancer treatment technologies, including hadron therapy, the market is expected to experience significant growth. Establishing new hadron therapy centers and partnerships with research institutions further supports market expansion. However, the high cost of hadron therapy equipment and the complexity of treatment facilities may hinder market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Hadron Therapy. The growth and trends of Hadron Therapy industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Hadron Therapy market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type of Particle Radiation

Electron Beam
Neutron Beam
Alpha Particle Beam
Proton Beam
Carbon Ion Beam
Beta Particle Beam

By Application

Pediatric Cancer
Prostate Cancer
Liver Cancer
Head & Neck Cancer
Bone & Soft Tissue Cancer
Lung Cancer
Eye Cancer

By End User

Government Universities
Hospitals
Research Institutions

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Hadron Therapy market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Hadron Therapy market include Koninklijke Philips N.V., Optivus Proton Therapy Inc, Hitachi Ltd, Sumitomo Corporation, Mitsubishi Electric Corporation, Elekta, IBA Worldwide, Advanced Oncotherapy, Varian Medical Systems Inc, Mevion Medical Systems, ProNova Solutions Llc, ProTom International. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. HADRON THERAPY - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type of Particle Radiation
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End User
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL HADRON THERAPY MARKET ANALYSIS BY TYPE OF PARTICLE RADIATION

5.1. Overview By Type of Particle Radiation
5.2. Historical and Forecast Data Analysis By Type of Particle Radiation
5.3. Electron Beam Historic and Forecast Sales By Regions
5.4. Neutron Beam Historic and Forecast Sales By Regions
5.5. Alpha Particle Beam Historic and Forecast Sales By Regions
5.6. Proton Beam Historic and Forecast Sales By Regions
5.7. Carbon Ion Beam Historic and Forecast Sales By Regions
5.8. Beta Particle Beam Historic and Forecast Sales By Regions

6. GLOBAL HADRON THERAPY MARKET ANALYSIS BY APPLICATION

6.1. Overview By Application
6.2. Historical and Forecast Data Analysis By Application
6.3. Pediatric Cancer Historic and Forecast Sales By Regions
6.4. Prostate Cancer Historic and Forecast Sales By Regions
6.5. Liver Cancer Historic and Forecast Sales By Regions
6.6. Head & Neck Cancer Historic and Forecast Sales By Regions
6.7. Bone & Soft Tissue Cancer Historic and Forecast Sales By Regions
6.8. Lung Cancer Historic and Forecast Sales By Regions
6.9. Eye Cancer Historic and Forecast Sales By Regions

7. GLOBAL HADRON THERAPY MARKET ANALYSIS BY END USER

7.1. Overview By End User
7.2. Historical and Forecast Data Analysis By End User
7.3. Government Universities Historic and Forecast Sales By Regions
7.4. Hospitals Historic and Forecast Sales By Regions
7.5. Research Institutions Historic and Forecast Sales By Regions

8. GLOBAL HADRON THERAPY MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE HADRON THERAPY COMPANIES

9.1. Hadron Therapy Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF HADRON THERAPY INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Koninklijke Philips N.V.
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Optivus Proton Therapy Inc
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Hitachi Ltd
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Sumitomo Corporation
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Mitsubishi Electric Corporation
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Elekta
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. IBA Worldwide
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Advanced Oncotherapy
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Varian Medical Systems Inc
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. Mevion Medical Systems
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments
10.13. ProNova Solutions Llc
- 10.13.1 Company Overview
- 10.13.2 Company Revenue
- 10.13.3 Products
- 10.13.4 Recent Developments
10.14. ProTom International
- 10.14.1 Company Overview
- 10.14.2 Company Revenue
- 10.14.3 Products
- 10.14.4 Recent Developments